Cochlear Implant Bilateral denied as non-formulary by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for cochlear implant bilateral are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Codes a Bilateral Cochlear Implant as Non-Formulary

Although cochlear implants are surgical devices rather than pharmacy drugs, some BCBS plans route implant approvals through a benefits-tiering or preferred-vendor framework. A "non-formulary" or "non-preferred" denial in this context usually means the specific implant system or device brand submitted is not on the plan's preferred device list, or that the facility or implant center is not contracted as a preferred provider for this technology. It can also arise from a coding mismatch in how the claim was submitted.

## Why This Denial Is Appealable

A non-formulary device denial does not mean the implant is excluded from your benefits. Most BCBS plans contain an exceptions process that allows coverage of non-preferred devices when a clinically compelling reason exists — including when the preferred alternative is contraindicated, unavailable, or clinically inferior for a specific patient's anatomy or hearing profile. The plan must disclose its exceptions criteria.

## Your Federal Appeal Rights

• Internal appeal: Request the denial letter in full and ask specifically which preferred device or facility the plan would have approved. This identifies whether the denial is about the device model, the provider, or a coverage exclusion.
• Exception request: File a formulary or device-tier exception simultaneously with or before your formal appeal, supported by a prescriber letter explaining why the requested system is medically necessary for this patient.
• External review (ACA §2719): If the denial constitutes a coverage determination rather than a pure tier placement, you are entitled to independent external review. An expedited track (72-hour decision) is available when health is at serious risk.
• ERISA §503: Employer plan members are entitled to all documents, guidelines, and clinical criteria used in the denial decision.
• Timeline: Internal appeal deadlines are stated on your denial notice — typically 180 days. External review is generally available within four months of final internal denial.

## Documentation to Gather

• Prescriber letter addressing device specifics: The implanting surgeon or audiologist should explain why the requested cochlear implant system — its specific features, compatibility with the patient's anatomy, or programming flexibility — is medically necessary for this patient, and why a substitution to a preferred device would be inappropriate.
• Audiological candidacy documentation: Full evaluation records establishing candidacy for cochlear implantation in both ears.
• Insurance verification / benefit plan language: Obtain the actual plan document or Summary Plan Description and locate the language covering cochlear implants and durable medical equipment to confirm the device is a covered benefit class.
• Facility credentials: If the denial relates to the implant center, gather the center's accreditation, surgeon credentials, and volume/outcomes documentation.

## Criteria-Mapping Structure

Request BCBS's published preferred-device list and the exceptions criteria document. Then construct a mapping:

| Plan Requirement for Exception Approval | Supporting Documentation | |---|---| | [Copy each exception criterion verbatim] | [Cite chart note, letter, or evaluation addressing it] |

If the plan's preferred alternative device exists, address explicitly why it is not appropriate for this patient. A prescriber attestation should accompany every criterion.